Meeting of the Board of Directors is scheduled to be held on May 28, 2026 to consider and approve Audited Financial Results of the Company and recommendation of Dividend on equity shares ....
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lincoln Pharmaceuticals has announced a board meeting on May 28, 2026 to review and approve the audited standalone and consolidated financial results for Q4 and the financial year ended March 31, 2026. The meeting will also consider recommending a dividend on equity shares, if any. The company had closed its trading window from April 1, 2026, which will reopen 48 hours after the results become publicly available. This is a routine regulatory intimation under SEBI listing regulations and does not contain actual financial performance data.
This is a standard board meeting notice with no concrete dividend commitment ('if any'). Shareholders should await the actual results announcement on May 28, 2026 for clarity on financial performance and any dividend payout.